Intramucosal inoculation of squamous cell carcinoma cells in mice for tumor immune profiling and treatment response assessment

Keyphrases

• Tumor 100%
• Treatment Monitoring 100%
• Inoculation 100%
• Head-and-neck Squamous Cell Carcinoma (HNSCC) 100%
• Squamous Carcinoma Cells 100%
• Immune Treatment 100%
• Tumor Immune Profiling 100%
• Murine Cells 66%
• Orthotopic Model 66%
• Murine Model 33%
• Myeloid Cells 33%
• Clinical Features 33%
• Novel Therapeutics 33%
• Human Disease 33%
• In Cancer 33%
• High Prevalence 33%
• Flow Cytometric Analysis 33%
• Improved Patient Outcomes 33%
• Disease Mechanisms 33%
• Tumor Microenvironment 33%
• Immune Cells 33%
• Treatment Resistance 33%
• Therapeutic Strategies 33%
• Physiological Features 33%
• Treatment Failure 33%
• Head-and-neck Region 33%
• Cancer Biology 33%
• Lymphatic Vasculature 33%
• Preclinical Development 33%
• Multi-parameter 33%
• Collagenase 33%
• Tumor Immunology 33%
• Vascular Density 33%
• Vascular Tumor 33%
• Microenvironmental Factors 33%
• Mass Cytometry 33%
• Metastasizing 33%
• Regional Lymph Nodes 33%
• Optimal Recovery 33%
• Buccal mucosa 33%
• Subcutaneous Implantation 33%
• Digestion Method 33%
• Tumor Digestion 33%

Immunology and Microbiology

• Neck 100%
• Squamous Cell Carcinoma Cell 100%
• Cell Line 66%
• Squamous Cell 66%
• Prevalence 33%
• Immunocompetent Cell 33%
• Myeloid 33%
• Lymph Node 33%
• Vascularization 33%
• Preclinical Study 33%
• Tumor Immunology 33%
• Mass Cytometry 33%
• Buccal Mucosa 33%